vcfirmsdirectory.com

Venture capital

New Leaf Venture Partners

New Leaf Venture Partners is a venture capital firm with offices in New York and Menlo Park that invests in healthcare companies, spanning biopharmaceuticals, medical devices and health information technology.

New York · Menlo ParkRegistered · New York
New investments · 12 months
Fund vehiclesPublic
9
9 active · US private fund
First cheque
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 26 Oct 2026, 16:50 CETSources: nlvpartners.com · SEC adviser filings

Investment activity

Round-by-round activity is part of PRO

See every round New Leaf Venture Partners joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is New Leaf Venture Partners right for your round?

Is New Leaf Venture Partners a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
9
9 active · US private fund
SEC adviser filings
First cheque
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.

NEW LEAF BIOPHARMA OPPORTUNITIES II, L.P.US private fund · Active · United States · $120.7M gross assets · filed 30 Mar 2026
NEW LEAF VENTURES IV, L.P.US private fund · Active · United States · $94.4M gross assets · filed 30 Mar 2026
NLV-II SPV-1, L.P.US private fund · Active · United States · $90.8M gross assets · filed 30 Mar 2026
NEW LEAF VENTURES III, L.P.US private fund · Active · United States · $62.4M gross assets · filed 30 Mar 2026
NLV CO-INVEST IV, L.P.US private fund · Active · United States · $16.8M gross assets · filed 30 Mar 2026
NLV CO-INVEST III, LLCUS private fund · Active · United States · $9M gross assets · filed 30 Mar 2026
NLV-II SPV-2, L.P.US private fund · Active · United States · $9M gross assets · filed 30 Mar 2026
NLV CO-INVEST II, LLCUS private fund · Active · United States · $5.3M gross assets · filed 30 Mar 2026
NEW LEAF VENTURES I, L.P.US private fund · Active · United States · $0 gross assets · filed 30 Mar 2026
Deployed (new cheques)
Next fund expected

Latest investments

BetaRounds New Leaf Venture Partners joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

1 round in the last 12 months

Round sizes, New Leaf Venture Partners’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

FlosonicsKalderosAbcuroElectra TherapeuticsSunbird BioCleerlyCogent BiosciencesDice TherapeuticsSanionaEscape Bioand 34 more

Portfolio and exits

Every company New Leaf Venture Partners backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where New Leaf Venture Partners puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet New Leaf Venture Partners

Events where New Leaf Venture Partners’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet New Leaf Venture Partners’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

18 Aug 2026New deal
30 Mar 2026Fund filingForm ADV filed by NEW LEAF VENTURE PARTNERS: 9 private funds, $408.4M in gross assets.SEC Form ADV · public record
22 Oct 2025New deal
30 Sep 2025New deal
12 Feb 2025New deal

Founders also look at

Frequently asked questions

New Leaf Venture Partners is based in New York, United States. It also has an office in Menlo Park.

9 fund vehicles are on public registers (SEC adviser filings), including NEW LEAF BIOPHARMA OPPORTUNITIES II, L.P., NEW LEAF VENTURES IV, L.P. and NLV-II SPV-1, L.P.

The firm backs companies that are driving innovation in healthcare, across biopharmaceuticals, medical devices and information-driven health technology, and supports entrepreneurs through successive funds, often holding board seats. From the firm’s own website.

New Leaf Venture Partners lists 44 portfolio companies on its website, including Flosonics, Kalderos, Abcuro, Electra Therapeutics and Sunbird Bio.

Firms whose websites list some of the same companies include Canaan, RA Capital and Agent Capital.

Know before New Leaf Venture Partners’s next round is announced.

PRO tracks New Leaf Venture Partners’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

New Leaf Venture PartnersGet New Leaf Venture Partners’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.